Deutetrabenazine is a prescription medication used to treat involuntary movement disorders, specifically chorea associated with Huntington’s disease and tardive dyskinesia in adults. It functions as a vesicular monoamine transporter 2 (VMAT2) inhibitor to control movement. The directory classifies it as a commercial API with a synthetic source/manufacturing origin. Other names for this substance include Austedo and Tetrabenazine-d6. Its PubChem CID is 73442840.
Deutetrabenazine
| CAS No | 1392826-25-3 |
|---|---|
| Molecular Formula | C19H27NO3 |
| Molecular Weight | 323.5 g/mol |
| Synonyms | (3S,11bS)-3-(2-methylpropyl)-9,10-bis(trideuteriomethoxy)-1,3,4,6,7,11b-hexahydrobenzo[a]quinolizin-2-one |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Deutetrabenazine is a prescription medication used to treat involuntary movement disorders, specifically chorea associated with Huntington's disease and tardive dyskinesia in adults.
The listed CAS number is 1392826-25-3.
The listed molecular formula is C19H27NO3.
The listed molecular weight is 323.5 g/mol.
(3S,11bS)-3-(2-methylpropyl)-9,10-bis(trideuteriomethoxy)-1,3,4,6,7,11b-hexahydrobenzo[a]quinolizin-2-one.
The source lists Austedo and Tetrabenazine-d6.